In the Boardroom
Refine Search
Pharmaceutical
USA-based PTC Therapeutics is to expand its global presence by adding key executives to leadership positions in the global commercial team and establishing its international headquarters in Dublin, Ireland. 17 September 2014
Pharmaceutical
Dutch biopharma company specializing in brain diseases, to-BBB, has appointed Anders Harfstrand as chief executive. 15 September 2014
Pharmaceutical
Oliver Siegel has been appointed as chief operating officer at Austrian vaccine specialist AFFiRiS AG, where he will take responsibility for business development, finance and administration. 9 September 2014
Pharmaceutical
Swedish drug developer Karolinska Development has appointed Bruno Lucidi as chief executive of the wholly-owned subsidiary KDev Oncology, and portfolio companies Aprea and Akinion Pharmaceuticals. 8 September 2014
Pharmaceutical
Belgian cell therapy company TiGenix has appointed Marie Paule Richard as chief medical officer, and Mary Carmen Diez as its vice president of medical affairs and new product commercialization. 1 September 2014
Pharmaceutical
French drug major Sanofi has replaced its North American chief Anne Whitaker with Jez Moulding, who will be head of the region’s pharma business following a senior management role in Japan and Asia Pacific. 28 August 2014
Pharmaceutical
French drugmaker Ipsen has appointed Cynthia Schwalm as president and chief executive of its North American operations. 21 August 2014
Pharmaceutical
Allergy specialist Allergan has appointed Jim Hindman as chief financial officer, effective immediately, replacing Jeff Edwards. 19 August 2014
Pharmaceutical
Switzerland-based Basilea Pharmaceutica has appointed David Veitch as its chief commercial officer. 19 August 2014
Pharmaceutical
Coming from her position as president of Sanofi’s North American pharma division, Anne Whitaker has been named chief executive of Synta Pharmaceuticals. 12 August 2014
Pharmaceutical
Astellas Pharma EMEA, the regional headquarters of Japanese drug major Astellas Pharma, has appointed Simon Dew as chief strategy officer. 7 August 2014
Pharmaceutical
Biopharmaceutical company Receptos has appointed Mary Szela and Richard Heyman to the board of directors. 29 July 2014
Pharmaceutical
Quebec-based cardiovascular drug development specialist Milestone Pharmaceuticals has announced the appointment of Francis Plat as chief medical officer. He is a cardiologist with extensive experience in cardio drug development. 21 July 2014
Pharmaceutical
US-based drug development and discovery company Aptuit has appointed Paul Overton as executive vice president, business development and marketing. He is now responsible for all of Aptuit’s sales and marketing activities. 16 July 2014
Pharmaceutical
Bayer Corporation, a US subsidiary of German drug major Bayer has hired Malini Moorthy as head of its litigation department from July 30. 16 July 2014
Pharmaceutical
US-based clinical-stage biopharma company Xencor has announced the appointment of Kurt Gustafson to its board of directors. He will also serve as chair of the audit and compensation committees for the company which develops engineer monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. 15 July 2014
Pharmaceutical
US-based biopharma Anthera Pharmaceuticals has appointed Chuck Olson as president of its subsidiary Alkira Therapeutics. 15 July 2014
Pharmaceutical
Merck Serono, the biotech unit of Germany’s Merck KGaA, has announced the appointment of Luciano Rossetti as executive vice president and global head of research and development. 14 July 2014
Pharmaceutical
Taiwan-based pharmaceutical company ScinoPharm (TWSE: 1789) says that its president and chief executive will retire at the end of July after 17 years of service. He will be succeeded by Dr Yung-Fa (Fred) Chen, who is currently the company’s vice president of research and development, and chief technology officer, from August 1. 11 July 2014
Pharmaceutical
US-based oncology specialist Jounce Therapeutics has announced the appointment of Richard Murray to chief executive officer. Dr Murray has more than 20 years of experience in building research and development capabilities in small startups and large pharmaceutical companies. He replaces the interim chief executive, Cary Pfeffer. 11 July 2014
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze